Packeiser, E.-M.; Engels, L.; Nolte, I.; Goericke-Pesch, S.; Murua Escobar, H.
MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines. Int. J. Mol. Sci. 2023, 24, 8136.
https://doi.org/10.3390/ijms24098136
AMA Style
Packeiser E-M, Engels L, Nolte I, Goericke-Pesch S, Murua Escobar H.
MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines. International Journal of Molecular Sciences. 2023; 24(9):8136.
https://doi.org/10.3390/ijms24098136
Chicago/Turabian Style
Packeiser, Eva-Maria, Leoni Engels, Ingo Nolte, Sandra Goericke-Pesch, and Hugo Murua Escobar.
2023. "MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines" International Journal of Molecular Sciences 24, no. 9: 8136.
https://doi.org/10.3390/ijms24098136
APA Style
Packeiser, E. -M., Engels, L., Nolte, I., Goericke-Pesch, S., & Murua Escobar, H.
(2023). MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines. International Journal of Molecular Sciences, 24(9), 8136.
https://doi.org/10.3390/ijms24098136